IGF-1 control paltusotine - QuickHealthLife

QuickHealthLife

QuickHealthLife

Latest Medical News

3 Min Read

Palsonify, FDA approves Palsonify, paltusotine acromegaly, acromegaly oral therapy, , once-daily oral treatment for acromegaly, acromegaly drug approval news, new treatments for acromegaly 2025, Palsonify drug price, Palsonify side effects, acromegaly management oral pill, Palsonify vs injectables, acromegaly therapeutic options, IGF-1 control paltusotine, safety of paltusotine

onJanuary 29, 2026

New Oral Therapy for Acromegaly: FDA Approves Palsonify (Paltusotine)

In 2025, the FDA officially approved Palsonify (paltusotine) as the first once-daily oral therapy for acromegaly.